Diagnosis Archives | VJHemOnc

Methods used in the diagnosis of hematological malignancies are constantly evolving, with novel technologies being developed, and an increased importance being placed on earlier diagnosis, patient risk stratification, and genomic testing. Discover the latest in the field in several disease areas, including multiple myeloma, CLL, AML, ALL, and lymphoma.

Multiple Myeloma

View all

The diagnostic and prognostic value of mass spectrometry in multiple myeloma

Noemí Puig • 13 May 2023

The role of the bone marrow microenvironment in myeloma disease progression

Paola Neri • 12 May 2023

CLL

View all

Delivering genomic testing results to patients with CLL

Kerry Rogers • 12 Dec 2022

The use of NGS in the diagnosis and treatment of Richter’s transformation

Thomas Kipps • 30 Nov 2022

AML

View all

Understanding genetic and non-genetic mechanisms involve in AML disease progression

Paresh Vyas • 24 Apr 2023

Challenges with diagnosing MDS and future outlooks

Manoj Raghavan • 23 Apr 2023

ALL

View all

The importance of MRD assessment before alloSCT in ALL

David Marks • 24 Apr 2023

Improving risk stratification in ALL with risk scores & genomic studies to personalize therapy

David Marks • 24 May 2023

Lymphoma

View all

The importance of multidisciplinary collaboration in the classification of lymphomas

Daphne de Jong • 23 Apr 2023

Pitfalls in the diagnosis of lymphoid malignancies: interpreting PET scans

Wendy Osborne • 24 Apr 2023

Updates in the WHO classification for lymphoma and how this may impact clinical practice

Daphne de Jong • 23 Apr 2023

A-HIPI, a novel prognostic model for advanced HL & outcomes of elderly patients with HL in Australia

Eliza Hawkes • 12 Dec 2022